Evidence map›Paper›PMID 21737569›Full record

ReviewMolecular pharmacology2011

Understanding molecular recognition by G protein βγ subunits on the path to pharmacological targeting.

Yuan Lin, Alan V Smrcka

Open access · bronzeAbstract readReview
In one paragraph

Review in Molecular pharmacology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 73 citations in OpenAlex.

  1. Review
  2. Article
  3. Coincident Regulation of PLCMolecular pharmacology · 2022
    Article
  4. Review
  5. Review
  6. The structural basis for an on-off switch controlling Gβγ-mediated inhibition of TRPM3 channels.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  7. Article
  8. A Comparison of the Ability of LeuMolecular pharmacology · 2019
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. βNature chemical biology · 2017
    Article
  16. Article
  17. Article
  18. Article
  19. Biased agonism: An emerging paradigm in GPCR drug discovery.Bioorganic & medicinal chemistry letters · 2016
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Yuan LinDepartment of Pharmacology, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
Alan V Smrcka
University of Rochester · US

Funding

Selective Targeting of G Protein beta gamma Subunits with Small MoleculesR01GM081772 · NIGMS · UNIVERSITY OF ROCHESTER · PI SMRCKA, ALAN V. · 2008 to 2017
$3.2M
NIGMS NIH HHS R01 GM081772NIGMS NIH HHS R01-GM081772
6 · The paper itself

Abstract

Heterotrimeric G proteins, composed of Gα and Gβγ subunits, transduce extracellular signals via G-protein-coupled receptors to modulate many important intracellular responses. The Gβγ subunits hold a central position in this signaling system and have been implicated in multiple aspects of physiology and the pathophysiology of disease. The Gβ subunit belongs to a large family of WD40 repeat proteins with a circular β-bladed propeller structure. This structure allows Gβγ to interact with a broad range of proteins to play diverse roles. How Gβγ interacts with and regulates such a wide variety of partners yet maintains specificity is an interesting problem in protein-protein molecular recognition in signal transduction, where signal transfer by proteins is often driven by modular conserved recognition motifs. Evidence has accumulated that one mechanism for Gβγ multitarget recognition is through an intrinsically flexible protein surface or "hot spot" that accommodates multiple modes of binding. Because each target has a unique recognition mode for Gβγ subunits, it suggests that these interactions could be selectively manipulated with small molecules, which could have significant therapeutic potential.

Indexed as

AnimalsCrystallography, X-RayDrug Delivery SystemsGTP-Binding Protein beta SubunitsGTP-Binding Protein gamma SubunitsHumansMolecular Targeted TherapyProtein BindingG-protein Beta gammaGTP-Binding Protein beta SubunitsGTP-Binding Protein gamma Subunits

Identifiers

PMID21737569
PMCPMC3187535
OpenAlexW2096548546

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.